bioMérieux ConnectionAn educational resource brought to you by bioMérieux, Inc.
An educational resource brought to you by bioMérieux, Inc.
The COVID-19 pandemic poses a threat to our antibiotic infrastructure, which is already compromised due to a lack of new therapies. That threat makes antimicrobial stewardship even more important.
“We have found that deep-sea microorganisms, especially actinomycetes, are an attractive, untapped source for the discovery of anti-infective agents,” said Guojun Wang, Ph.D., assistant research professor at FAU Harbor Branch.
A Baylor team’s research suggests that that the dramatic increase in nosocomial Clostridium difficile infections can be attributed, at least partially, to a type of sugar called trehalose.
Trehalose, a type of carbohydrate (sugar), could hold the key to a new treatment for diabetes and other metabolic diseases, but it might also fuel more severe Clostridium difficile (C. difficile) infections.
COVID-19 is not just any respiratory virus. Researchers have quickly...
Amid the spread of COVID-19, testing for SARS-COV-2, the virus...